CAS 73278-98-5

Chemistry, 1 End Use API, 2 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: 73278-98-5, [3-(1-piperidinylmethyl)phenoxy]propylamine, 3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine, Roxatidine impurity 2, (3-(1-piperidinylmethyl)phenoxy)propylamine, 3-(3-(piperidinomethyl)phenoxy)propylamine

Molecular Formula

C₁₅H₂₄N₂O

Molecular Weight

248.36 g/mol

InChI Key

VQSXCZMVUMSITD-UHFFFAOYSA-N

1 2D Structure

CAS 73278-98-5

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine

2.1.2 InChI

InChI=1S/C15H24N2O/c16-8-5-11-18-15-7-4-6-14(12-15)13-17-9-2-1-3-10-17/h4,6-7,12H,1-3,5,8-11,13,16H2

2.1.3 InChI Key

VQSXCZMVUMSITD-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CCN(CC1)CC2=CC(=CC=C2)OCCCN

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 73278-98-5

2. [3-(1-piperidinylmethyl)phenoxy]propylamine

3. 3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine

4. Roxatidine Impurity 2

5. (3-(1-piperidinylmethyl)phenoxy)propylamine

6. 3-(3-(piperidinomethyl)phenoxy)propylamine

7. 3-[3-(piperidinomethyl)phenoxy]propylamine

8. 3-{3-(piperidinomethyl)phenoxy}propylamine

9. 3-[3-(1-piperidinylmethyl)phenoxy]propanamine

10. 3-[3-[1-piperidinylmethyl]phenoxy]propanamine

11. 3-[3-(1-piperidinylmethyl)phenoxy]propylamine

12. 3-[3-(1-piperidylmethyl)phenoxy]-1-propanamine

13. Chembl353792

14. Schembl5288663

15. Dtxsid10436937

16. Bcp33841

17. Mfcd07787282

18. Zinc21992745

19. Akos015904214

20. 3-(m-piperidinomethylphenoxy)propylamine

21. N-[3-(3-aminopropoxy)benzyl]piperidine

22. 3-(3-piperidinomethylphenoxy)propylamine

23. N-[3-(3-aminopropoxy)benzyl] Piperidine

24. Sy293178

25. 3-[3-(piperidinomethyl)phenoxy]propaneamine

26. Cs-0455361

27. Ft-0641452

28. 3-[3-(1-piperidinomethyl)phenoxy]propylamine

29. 3-[3-(l-piperidinomethyl)phenoxyl]propytamine

30. N-3-[3-(piperidinomethyl)phenoxy]propylamine

31. 3-[3-(1-piperidinylmethyl) Phenoxy]propanamine

32. 3-[3-(1-piperidinylmethyl)phenoxy]propyl]amine

33. 3-[3-[(1-piperidinyl)methyl]phenoxy]propanamine

34. 3-[3-[(1-piperidinyl)methyl]phenoxy]propylamine

35. 278p985

36. 3-[3-(1-piperidinylmethyl)phenoxy]-1-propanamine

37. 3-[3-[(1-piperidinyl)-methyl]phenoxy]propylamine

38. 3-[3-[(1-piperidinyl)methyl]phenoxy]propaneamine

39. A837773

40. N-{3-[3-(1-piperidinomethyl)phenoxy]}propylamine

41. 3-[3-(1-piperidinylmethyl) Phenoxy]-1-propanamine

42. 3-{3-[(piperidin-1-yl)methyl]phenoxy}propan-1-amine

43. 3-[3-(1-piperidylmethyl)phenoxy]propan-1-amine;3-(3-(piperidin-1-ylmethyl)phenoxy)propan-1-amine

2.3 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₂₄N₂O
Molecular Weight	248.36 g/mol
XLogP3	2.5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	6
Exact Mass	248.188863393 g/mol
Monoisotopic Mass	248.188863393 g/mol
Topological Polar Surface Area	38.5 Å²
Heavy Atom Count	18
Formal Charge	0
Complexity	217
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Tianjin Hankang Pharmaceutical Biot...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

3-(3-(Piperidin-1-ylmethyl)phenoxy)propan-1-amine

PDF Supplier PDF

URL Supplier Web Content

CAS Number

73278-98-5

End Use API

Roxatidine

About the Company

Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enter...

Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enterprise in China. Focused on generic drugs while venturing into innovative ones, the group is dedicated to offering comprehensive solutions to the industry. Presently, Hankang has crafted over 200 varieties for 600+ domestic and international companies, serving 10+ innovative drugs. It has successfully developed more than 10 initial generic drugs, with over 20 varieties endorsed by the top three domestic companies and 30 exceeding a 100 million output value.

ASK
US